Vedolizumab是一种整联蛋白受体拮抗剂，是一种在中国仓鼠卵巢细胞中产生的人源化IgG1单克隆抗体，可与人α4β7整联蛋白结合。Vedolizumab的分子量约为147千道尔顿。 Vedolizumab生物类似药-超低内毒素该产品同种型对照：Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 缓冲液：ICH3001-100ml，nICH3002-100ml，nICH3003-100ml， 浓度：1.0 - 5.0 mg/ml 纯度：>95% by SDS-PAGE and HPLC 内毒素：≤ 0.1 EU/mg as determined by the LAL method 制剂：Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
